Skip to content

Author

L. Muscarella

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

with therapeutic

All cases of combined carcinoid and non-small cell lung cancer are summarized, focusing on clinical, morphological, and biological features, suggesting the need to recognize and include this entity as a separate class, in particular for its distinct therapeutic implications.

N. Rossi, P. Parente, Luisella Righi et al. · 0 citations
Open access Aug 2026

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids

Lung neuroendocrine tumours (NETs, also known as carcinoids) are rapidly rising in incidence worldwide but have unknown aetiology and limited therapeutic options beyond surgery. The current WHO classification, based on mitotic count and presence or absence of necrosis, divides lung NETs into grade-1 typical, and grade-...

A. Sexton-Oates, É. Mathian, N. Candeli et al. · 1 citation
Review Open access Aug 2026

Epigenetic profiling of circulating cell-free DNA for early detection and minimal residual disease assessment in lung cancer: a focus on DNA methylation

The biological and clinical relevance of the epigenetic landscape of cfDNA in LC patients is explored, particularly focusing on DNA methylation-based biomarkers and their evolving applications towards early diagnosis and post-surgical monitoring of minimal residual disease (MRD).

T. D. Bazan Russo, V. Gristina, M. D. Delcuratolo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.